|
OIG to Continue Investigating FDA’s REMS Program in 2013
During the coming year, the HHS Office of Inspector General (OIG) will continue examining the risk evaluation and mitigation strategies (REMS) program and expects to release findings next year, the office says in its fiscal 2013 work plan.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives